| Product Name | MF | CAS | Details |
|---|
| afatinib | C24H25ClFN5O3 | 439081-18-2 | Details |
| 2-((2,6-difluorobenzyl)(ethoxycarbonyl)amino)-4-((dimethylamino)methyl)-5-(4-nitrophenyl)thiophene-3-carboxylic acid | C24H23F2N3O6S | 1589503-95-6 | Details |
| Phosphonium, [[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]me | C34H34FN3O2PS.Br | 885477-83-8 | Details |
| 4-(4-Fluorophenyl)-6-isopropyl-2-[(N-methyl-N-methylsufonyl)amino]pyrimidine-5-yl-methanol | C16H20FN3O3S | 147118-36-3 | Details |
| relugolix | C29H27F2N7O5S | 737789-87-6 | Details |
| 3-AMINO-6-METHOXYPYRIDAZINE | C5H7N3O | 7252-84-8 | Details |
| 4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester | C22H20N4O6 | 536759-91-8 | Details |
| Lesinurad | C17H14BrN3O2S | 878672-00-5 | Details |
| Apixaban | C25H25N5O4 | 503612-47-3 | Details |
| 3-Morpholino-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one | C15H17N3O4 | 503615-03-0 | Details |
| 4-(carboxymethyl)-2-((R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)-6-oxo-1,3,2-dioxaborinane-4-carboxylicacid | C20H23BCl2N2O9 | 1201902-80-8 | Details |
| Ethyl chloro[(4-Methoxyphenyl)hydrazono]acetate | C11H13ClN2O3 | 27143-07-3 | Details |
| ethyl 2-((2,6-difluorobenzyl)(ethoxycarbonyl)amino)-4-methyl-5-(4-nitrophenyl)thiophene-3-carboxylate | C24H22F2N2O6S | 308831-94-9 | Details |
| 6-Bromo-3-hydroxypyrazine-2-carboxamide | C5H4BrN3O2 | 259793-88-9 | Details |
| Oseltamivir impurities | C11H18N2O4 | 903907-74-4 | Details |
| Levetiracetam impurities | C8H14N2O3 | 1933471-30-7 | Details |
| salbutamol impurities | C13H21NO3 | Details |
| Pranoprofen impurities | C17H19NO4 | 143436-36-6 | Details |
| Parecoxib Sodium | C19H19N2NaO4S | 198470-85-8 | Details |
| Mirabegron impurities | C16H21ClN2 | 1581285-26-8 | Details |
| 2-Chloro-2',4'-difluoroacetophenone | C8H5ClF2O | 51336-94-8 | Details |
| 3-benzyl-6-broMo-2-chloroquinoline | C16H11BrClN | 654655-68-2 | Details |
| Formoterol impurities | Details |
| tert-Butyl (4R-cis)-6-[(acetyloxy)methyl]-2,2-dimethyl-1,3-dioxane-4-acetate | C15H26O6 | 154026-95-6 | Details |
| Ganciclovir impurities | C9H13N5O4 | 82410-32-0 | Details |
| favipiravir | C5H4FN3O2 | 259793-96-9 | Details |
| Ritonavir impurities | C23H32N2O3 | 1414933-89-3 | Details |
| Palbociclib impurities | Details |
| Ethyl 6-(4-aMinophenyl)-1-(4-Methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate | C22H22N4O4 | 503615-07-4 | Details |
| 3-Oxocyclobutanecarboxylic acid | C5H6O3 | 23761-23-1 | Details |
| L-Calcium Levofolinate | C20H25CaN7O7 | 80433-71-2 | Details |
| 4-Amino-2-hydroxy-5-methylpyridine | C6H8N2O | 95306-64-2 | Details |
| Levosimendan impurities | 139052-02-1 | Details |
| 3-Methyl-1,2,4-thiadiazole-5-carbohydrazide | C4H6N4OS | 1375066-73-1 | Details |
| Isoquinoline, 4-(3-bromophenyl)-6,8-dichloro-1,2,3,4-tetrahydro-2-methyl-, (4S)- | C16H14BrCl2N | 1870821-29-6 | Details |
| 1H-Pyrrole-3-carboxylic acid, 4-methyl-5-[2-(trifluoromethyl)phenyl]-, ethyl ester | C15H14F3NO2 | 1631030-76-6 | Details |
| Gefitinib impurities | C22H23ClFN3O4 | 1608115-59-8 | Details |
| Isavuconazole | C22H17F2N5OS | 241479-67-4 | Details |
| epinephrine impurities | Details |
| Tafluprosttrade | C25H34F2O5 | 209860-87-7 | Details |
| Carbamic acid, N-[cis-3-(methylamino)cyclobutyl]-, phenylmethyl ester, hydrochloride (1:1) | C13H19ClN2O2 | 2204290-99-1 | Details |
| Caronic anhydride | C7H8O3 | 67911-21-1 | Details |
| folic acid impurities | C7H7NO2 | 150-13-0 | Details |
| Isavuconazonium sulfate | C35H36F2N8O9S2 | 946075-13-4 | Details |
| Teriflunomide impurities | C12H9F3N2O2 | 62004-05-1 | Details |
| 5-Bromo-[1,2,4]triazolo[1,5-a]pyridin-2-amine | C6H5BrN4 | 1010120-55-4 | Details |
| Filgotinib | C21H23N5O3S | 1206161-97-8 | Details |
| Rebamipide impurities | C19H15ClN2O4 | 90098-04-7 | Details |
| Dabigatran ester | C34H41N7O5 | 211915-06-9 | Details |
| BENZYL N-[(1S,3S)-3-(METHYLAMINO)CYCLOBUTYL]CARBAMATE | C13H18N2O2 | 1353501-22-0 | Details |
| Thiomorpholine-1,1-dioxide | C4H9NO2S | 39093-93-1 | Details |
| Glycine, N-[(1,1-diMethylethoxy)carbonyl]-N-Methyl-, [2-[[(1-chloroethoxy)carbonyl]MethylaMino]-3-pyridinyl]Methyl ester | C18H26ClN3O6 | 338990-31-1 | Details |
| Isavuconazole impurities | Details |
| Landiolol impurities | C19H29N3O6 | 190601-22-0 | Details |
| rotigotine impurities | C19H25NOS | 99755-59-6 | Details |
| Tenapanor | C50H68Cl6N8O10S2 | 1234365-97-9 | Details |
| N-Boc-3,6-dioxaoctane-1,8-diamine | C11H24N2O4 | 153086-78-3 | Details |
| 4-CYANO-2-METHOXYBENZALDEHYDE | C9H7NO2 | 21962-45-8 | Details |
| prostaglandin impurities | Details |
| (R)-4-(2,4-diMethoxybenzyl)-3-Methylpiperazin-2-one | C14H20N2O3 | 1383146-20-0 | Details |
| Loratadine impurities | C20H21N | 50603-12-8 | Details |
| Carbamic acid, N-[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]-, ethyl ester | C16H16N4O4S | 1869118-24-0 | Details |
| (1R,2R)-(-)-trans-cyclohexane-1,2-dicarboxylic acid | C8H12O4 | 46022-05-3 | Details |
| (1R,2S,5S)-6,6-DIMETHYL-3-AZA-BICYCLO[3.1.0]HEXANE-2-CARBOXYLIC ACID METHYL ESTER HYDROCHLORIDE | C9H16ClNO2 | 565456-77-1 | Details |
| 6,6-Dimethyl-3-azabicyclo[3.1.0]hexane | C7H13N | 943516-54-9 | Details |
| N-[5-[(4-Methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]carbamic acid 1,1-dimethylethyl ester | C18H20N4O4S | 1201187-44-1 | Details |
| Edoxaban | C24H30ClN7O4S | 480449-70-5 | Details |
| (1R,2S)-rel-2-(3,4-Difluorophenyl)cyclopropanaMine hydrochloride | C9H10ClF2N | 1156491-10-9 | Details |
| 2-((1R,5S,6S)-6-(aminomethyl)-3-ethylbicyclo[3.2.0]hept-3-en-6-yl)acetic acid | C12H19NO2 | 1138245-13-2 | Details |
| 3-(dimethylamino)-1-(naphthalen-5-yl)propan-1-one | C15H17NO | 10320-49-7 | Details |
| (3aR,4S,7R,7aS) 4,7-Methano-1H-isoindole-1,3(2H)-dione | C9H11NO2 | 14805-29-9 | Details |
| 7,8-difluoro-6,11-dihydro-Dibenzo[b,e]thiepin-11-ol | C14H10F2OS | 1985607-83-7 | Details |
| 3-(1-Piperazinyl)-1,2-benzisothiazole | C11H13N3S | 87691-87-0 | Details |
| PF-07321332；PAXLOVID | C23H32F3N5O4 | 2628280-40-8 | Details |
| 2-[[(3aR,4S,6R,6aS)-6-[[5-amino-6-chloro-2-(propylthio)-4-pyrimidinyl]amino]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-ethanol | C17H27ClN4O4S | 376608-74-1 | Details |
| Fezolinetant | C16H15FN6OS | 1629229-37-3 | Details |
| Methyl 3-(benzyloxy)-1-((tert-butoxycarbonyl)amino)-4-oxo-1,4-dihydropyridine-2-carboxylate | C19H22N2O6 | 2136287-59-5 | Details |
| 6-chloro-2-methyl-2H-indazol-5-amine | C8H8ClN3 | 1893125-36-4 | Details |
| TICAGRELOR | C23H28F2N6O4S | 274693-27-5 | Details |
| (R,R)-1,2-bis(methanesulfonyloxymethyl)cyclohexane | C10H20O6S2 | 186204-35-3 | Details |
| Upadacitinib | C17H19F3N6O | 1310726-60-3 | Details |
| 1,3,5-Triazine-2,4(1H,3H)-dione, 3-(1,1-dimethylethyl)-6-(ethylthio)- | C9H15N3O2S | 1360105-53-8 | Details |
| 2,4,5-Trifluorobenzyl bromide | C7H4BrF3 | 157911-56-3 | Details |
| 2-bromo-5-tosyl-5H-pyrrolo[2,3-b]pyrazine | C13H10BrN3O2S | 1201186-54-0 | Details |
| 3-benzyl-6-bromo-2-methoxyquinoline | C17H14BrNO | 654655-69-3 | Details |
| (1R,2R)-2-(3,4-difluorophenyl)cyclopropanamine(S)-(carboxylato(phenyl)methyl)holmium | C17H17F2NO3 | 376608-71-8 | Details |
| baloxavirmarboxil impurities | C27H23F2N3O7S | 1985606-14-1 | Details |
| Diphenyl phosphorochloridate | C12H10ClO3P | 2524-64-3 | Details |
| (3aR,7aR)-4'-(1,2-Benzisothiazol-3-yl)octahydrospiro[2H-isoindole-2,1'-piperaziniuM] Methanesulfonate | C19H26N4O3S2 | 186204-37-5 | Details |
| Finerenone | C21H22N4O3 | 1050477-31-0 | Details |
| (1R,5S)-3-ethyl-Bicyclo[3.2.0]hept-3-en-6-one | C9H12O | 1235479-61-4 | Details |
| 3-CHLOROMETHYL-1-METHYL-1H-[1,2,4]TRIAZOLE | C4H6ClN3 | 135206-76-7 | Details |
| (1R,2R)-1,2-CYCLOHEXANEDIMETHANOL | C8H16O2 | 65376-05-8 | Details |
| 3-(DiMethylaMino)-1-(naphthalen-1-yl)propan-1-one hydrochloride | C15H18ClNO | 5409-58-5 | Details |
| 4,6-dichloro-2-(propylthio)pyriMidin-5-aMine | C7H9Cl2N3S | 145783-15-9 | Details |
| 2-((3aR,4S,6R,6aS)-6-aMino-2,2-diMethyltetrahydro-3aH-cyclope nta[d][1,3]dioxol-4-yloxy)ethanol L-tataric acid | C14H25NO10 | 376608-65-0 | Details |
| methyl (S)-2-((tert-butoxycarbonyl)amino)-3-((S)-2-oxopyrrolidin-3-yl)propanoate | C13H22N2O5 | 328086-60-8 | Details |
| (3R,4S)-3-(2-bromoacetyl)-4-ethyl-1-Pyrrolidinecarboxylic acid, phenylmethyl ester | C16H20BrNO3 | 1428243-26-8 | Details |
| (R)-7-(Benzyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione | C17H17N3O4 | 1985607-70-2 | Details |
| Product Total： Product Page： | ||||
| 1 2 | ||||